We previously found a severe impairment of cardiac uptake of I-metaiodobenzylguanidine (MIBG), an analogue of norepinephrine, on myocardial scintigraphy in a small group of patients with cardiac syndrome X (CSX), suggesting a dysfunction of cardiac adrenergic nerve fibres. In this study, we assessed the consistency of these previous findings in a larger group of these patients.
Di Monaco, A., Bruno, I., Calcagni, M. L., Nerla, R., Lamendola, P., Barone, L., Scalone, G., Mollo, R., Coviello, I., Bagnato, A., Sestito, A., Giordano, A., Lanza, G. A., Crea, F., Cardiac adrenergic nerve function in patients with cardiac syndrome X, <<JOURNAL OF CARDIOVASCULAR MEDICINE>>, 2010; 11 (3): 151-156. [doi:10.2459/JCM.0b013e328330321d] [http://hdl.handle.net/10807/10985]
Cardiac adrenergic nerve function in patients with cardiac syndrome X
Di Monaco, Antonio;Bruno, Isabella;Calcagni, Maria Lucia;Nerla, Roberto;Lamendola, Priscilla;Barone, Lucy;Scalone, Giancarla;Mollo, Roberto;Coviello, Ilaria;Sestito, Alfonso;Giordano, Alessandro;Lanza, Gaetano Antonio;Crea, Filippo
2010
Abstract
We previously found a severe impairment of cardiac uptake of I-metaiodobenzylguanidine (MIBG), an analogue of norepinephrine, on myocardial scintigraphy in a small group of patients with cardiac syndrome X (CSX), suggesting a dysfunction of cardiac adrenergic nerve fibres. In this study, we assessed the consistency of these previous findings in a larger group of these patients.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
